DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

Myriad Genetics (NASDAQ: MYGN)

33.59 -0.77 (-2.24%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MYGN $33.59 -2.24%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.38
Previous Close $34.36
Daily Range $33.54 - $34.40
52-Week Range $31.56 - $42.50
Market Cap $2.4B
P/E Ratio 23.70
Dividend (Yield) $0.00 (0.0%)
Volume 418,246
Average Daily Volume 753,458
Current FY EPS $1.53




Diversified Services

Myriad Genetics (MYGN) Description

Myriad Genetics is focused on developing and marketing novel molecular diagnostic products. Website:

News & Commentary

3 Megatrends in Healthcare

These three megatrends could be largely responsible for value creation and the impetus for innovation within the healthcare sector throughout the remainder of the decade.

LabCorp (LH) Poised to Outshine Q1 Earnings Estimates - Analyst Blog

Will Quest Diagnostics' (DGX) Earnings Surprise in Q1? - Analyst Blog

Will Thermo Fisher's (TMO) Q1 Earnings Surprise Investors? - Analyst Blog

First Week of MYGN June 19th Options Trading

A Possible Glimpse Into the Future: Is a $1 Prostate Cancer Test on the Way?

A more accurate and significantly cheaper prostate cancer screening test? Find out what researchers at the University of Central Florida are up to -- and how it could transform prostate cancer diagnoses many years down the road.

Cowen Thinks 3 Life Science Stocks Can Beat Earnings Estimates

Myriad Genetics (MYGN) Shares Cross Above 200 DMA

MYGN May 22nd Options Begin Trading

Top 4 Stocks In The Research Services Industry With The Highest Revenue

See More MYGN News...

MYGN's Top Competitors

MYGN $33.59 (-2.24%)
Current stock: MYGN
GILD $103.70 (-1.44%)
Current stock: GILD
AMGN $167.91 (-0.74%)
Current stock: AMGN
BIIB $401.71 (-6.64%)
Current stock: BIIB